Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERBB2 | P04626 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | FYN | P06241 | 1/20 | 0.31 |
| ▸ | MAOA | P21397 | 1/20 | 0.31 |
| ▸ | ACHE | P22303 | 1/20 | 0.31 |
| ▸ | AHR | P35869 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10034238 | 0.86 | L3MBTL1 (0.46) | ERBB2CYP1A2FYNMAOAACHE | |
| SCHEMBL2601571 | 0.86 | L3MBTL1 (0.46) | ERBB2CYP1A2FYNMAOAACHE | |
| SCHEMBL2601583 | 0.78 | ERBB2 (0.33) | ERBB2CYP1A2FYNMAOAACHE | |
| SCHEMBL10034167 | 0.77 | — | — | |
| SCHEMBL2601544 | 0.77 | — | — | |
| SCHEMBL16574529 | 0.75 | L3MBTL1 (0.57) | ERBB2CYP1A2FYNMAOAACHE | |
| SCHEMBL10034251 | 0.74 | LDHA (0.32) | KDM4EATML3MBTL1 | |
| SCHEMBL2601605 | 0.74 | LDHA (0.32) | — | |
| SCHEMBL14706843 | 0.73 | L3MBTL1 (0.50) | ERBB2CYP1A2FYNMAOAACHE | |
| SCHEMBL14329575 | 0.72 | KDM4E (0.31) | KDM4EL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8455867-B2 | Organic light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2013-06-04 | — | — | US | disclosed |
| US-8431251-B2 | Heterocyclic compound and organic light-emitting device comprising the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2013-04-30 | — | — | US | disclosed |
| US-8405074-B2 | — | — | 2013-03-26 | — | — | US | disclosed |
| US-20130001524-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING THE SAME | SAMSUNG MOBILE DISPLAY CO., LTD. (KR) | 2013-01-03 | — | — | US | disclosed |
| US-20120097924-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG MOBILE DISPLAY CO., LTD. (KR) | 2012-04-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130001524-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING THE SAME | C9, C1S, C5 | ERBB2 3324/4885CYP1A2 315/4885FYN 4427/4885 |
| US-20120097924-A1 | ORGANIC LIGHT-EMITTING DEVICE | KCNT1, KCNA1, TRPA1 | ERBB2 3450/4885CYP1A2 336/4885FYN 3555/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.